No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

Rarity of malignant mesothelioma prior to the widespread commercial introduction of asbestos: the Mount Sinai autopsy experience 1883-1910

Our plain-English summary of Rarity of malignant mesothelioma prior to the widespread commercial introduction of asbestos: the Mount Sinai autopsy experience 1883-1910, by J.A. Strauchen (American Journal of Industrial Medicine, 2011).

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

The study

Abstract

Background: Most malignant mesotheliomas are related to asbestos exposure. Whether malignant mesothelioma occurs in the absence of asbestos exposure remains unsettled. To address this question we reviewed a series of 2,025 autopsies performed at the Mount Sinai Hospital between 1883 and 1910, prior to the widespread commercial introduction of asbestos.

Methods: Retrospective autopsy review.

Results: No cases of malignant mesothelioma were identified in 2,025 autopsies performed between 1883 and 1910.

Conclusions: Malignant mesothelioma was rare prior to the widespread commercial introduction of asbestos.

Copyright © 2011 Wiley-Liss, Inc.

In plain English

This brief report reviewed the records of 2,025 autopsies performed at the Mount Sinai Hospital in New York City between February 1883 and December 1910, a period the author placed before the widespread commercial introduction of asbestos. No individual asbestos exposure was assessed. A case counted as mesothelioma if tumor involved the pleura, spread on the serosa, and no other tumor was found. Malignant tumors were found in 281 of the 2,025 autopsies (13.9%), most often cancers of the stomach or esophagus (73 cases) and of the colon and rectum (43 cases). Lung cancer accounted for 6 cases. No definite cases of malignant mesothelioma were identified. One 1903 case, recorded as a possible pleural "endothelioma," was judged more likely to be metastatic carcinoma from an unknown site. The author concluded that the incidence of malignant mesothelioma before widespread commercial use of asbestos was very low. The author noted limitations. No slides survive, and many records lacked microscopic findings. Only patients who died in the hospital and were autopsied were studied, and they were mostly poor and immigrant.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

  • Design: Retrospective review of historical autopsy records (brief report)
  • Who was studied: 2,025 autopsies performed at the Mount Sinai Hospital, New York City, between February 2, 1883 and December 31, 1910
  • Exposure: No individual asbestos exposure was assessed. The study period was chosen as one before the widespread commercial introduction of asbestos and before enough latency for asbestos-related mesothelioma to develop.
  • Main results:
    • Malignant tumors were identified in 281 of the 2,025 autopsies (13.9%)
    • Among the 281 malignant tumors, carcinoma of the stomach or esophagus was most common (73 cases, 26.0%), followed by carcinoma of the colon and rectum (43 cases, 15.3%)
    • Lung cancer was infrequent among the 281 malignant tumors (6 cases, 2.1%)
    • No definite cases of malignant mesothelioma were identified among the 2,025 autopsies
    • One 1903 autopsy in a 47-year-old woman, recorded as a possible primary pleural 'endothelioma' with metastases, was considered more likely to be metastatic carcinoma of unknown primary site
  • The authors' conclusion: The author concluded that the incidence of malignant mesothelioma before the widespread commercial introduction of asbestos was very low.
  • Limitations the authors state:
    • No slides survive. Early autopsy descriptions recorded only gross findings, and microscopic findings were not provided in all cases.
    • The lack of histology in the early autopsy records limits the review.
    • The term 'mesothelioma' was not well established until 1931, and such tumors had been recorded under other names.
    • Distinguishing mesothelioma from pleural metastases of adenocarcinoma remains problematic.
    • Selection bias: only patients who died in the hospital and were autopsied were studied, and hospitals then served a predominantly indigent and immigrant population.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Mesothelioma.

Medical terms in this study, explained in our Lexicon: Mesothelioma, Autopsy, Asbestos Exposure.

Browse more research in American Journal of Industrial Medicine, or return to medical research.

Cited on this site

How to cite it

Cite the study

J.A. Strauchen. Rarity of malignant mesothelioma prior to the widespread commercial introduction of asbestos: the Mount Sinai autopsy experience 1883-1910. American Journal of Industrial Medicine 2011;54(6):467-9. doi:10.1002/ajim.20951. PMID: 21452191.

Cite our summary

“Rarity of malignant mesothelioma prior to the widespread commercial introduction of asbestos: the Mount Sinai autopsy experience 1883-1910.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/rarity-of-malignant-mesothelioma-prior-to-the-widespread-commercial.

ACL Doc numbers and their short links never change. See how to cite the Library.

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.